Etafenone

Etafenone

SCHEMBL1651223

CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1.[Cl-].[H+]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Etafenone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 16/20 0.65
▸ TSHR P16473 1/20 0.65
▸ KDM4E B2RXH2 1/20 0.62
▸ ALDH1A1 P00352 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ DRD2 P14416 1/20 0.52
▸ DRD1 P21728 1/20 0.52
▸ DRD3 P35462 1/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ SCN1A P35498 1/20 0.52
▸ SCN2A Q99250 1/20 0.52
▸ SCN3A Q9NY46 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etafenone SCHEMBL77987 0.97 ABCB1 (0.67) ABCB1TSHRKDM4EALDH1A1LMNA
Etafenone SCHEMBL29406308 0.97 ABCB1 (0.67) ABCB1TSHRKDM4EALDH1A1LMNA
Etafenone SCHEMBL219823 0.96 ABCB1 (0.66) ABCB1TSHRKDM4EALDH1A1LMNA
Etafenone SCHEMBL29846308 0.96 ABCB1 (0.66) ABCB1TSHRKDM4EALDH1A1LMNA
Etafenone SCHEMBL28142810 0.85 ABCB1 (0.52) ABCB1TSHRKDM4EALDH1A1LMNA
SCHEMBL10426054 0.84 ABCB1 (0.52) ABCB1TSHRKDM4EALDH1A1LMNA
Etafenone SCHEMBL13724598 0.82 ABCB1 (0.53) ABCB1TSHRKDM4EALDH1A1LMNA
SCHEMBL11338177 0.80 ALDH1A1 (0.76) ABCB1TSHRKDM4EALDH1A1LMNA
Hexobendine SCHEMBL28086174 0.80 SCN1A (0.55) ABCB1TSHRKDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL11671640 0.79 ALDH1A1 (0.74) ABCB1KDM4EALDH1A1LMNADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 — — US disclosed
US-7790905-B2 Pharmaceutical propylene glycol solvate compositions MCNEIL-PPC, INC. (US) 2010-09-07 — — US disclosed
EP-1697303-A4 CATALYTIC HYDROGENATION OF NITRILES TO PRODUCE CAPSAICINOID DERIVATIVES AND AMINE COMPOUNDS, AND METHODS FOR PURIFIYING AND OBTAINING THE POLYMORPHS THEREOF STIEFEL LABORATORIES (US) 2007-07-04 — — EP disclosed
EP-1697303-A1 CATALYTIC HYDROGENATION OF NITRILES TO PRODUCE CAPSAICINOID DERIVATIVES AND AMINE COMPOUNDS, AND METHODS FOR PURIFIYING AND OBTAINING THE POLYMORPHS THEREOF STIEFEL LABORATORIES, INC. (US) 2006-09-06 — — EP disclosed
US-20060047171-A1 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof STIEFEL LABORATORIES, INC. 2006-03-02 — — US disclosed
WO-2005068414-A1 CATALYTIC HYDROGENATION OF NITRILES TO PRODUCE CAPSAICINOID DERIVATIVES AND AMINE COMPOUNDS, AND METHODS FOR PURIFIYING AND OBTAINING THE POLYMORPHS THEREOF STIEFEL LABORATORIES, INC. (US) 2005-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047171-A1 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof HPD, HNMT, PRPH ABCB1 4188/4885TSHR 4814/4885KDM4E 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback